Page last updated: 2024-10-21

acebutolol and Lupus Erythematosus, Discoid

acebutolol has been researched along with Lupus Erythematosus, Discoid in 1 studies

Acebutolol: A cardioselective beta-1 adrenergic antagonist with little effect on the bronchial receptors. The drug has stabilizing and quinidine-like effects on cardiac rhythm, as well as weak inherent sympathomimetic action.
acebutolol : An ether that is the 2-acetyl-4-(butanoylamino)phenyl ether of the primary hydroxy group of 3-(propan-2-ylamino)propane-1,2-diol.

Lupus Erythematosus, Discoid: A chronic form of cutaneous lupus erythematosus (LUPUS ERYTHEMATOSUS, CUTANEOUS) in which the skin lesions mimic those of the systemic form but in which systemic signs are rare. It is characterized by the presence of discoid skin plaques showing varying degrees of edema, erythema, scaliness, follicular plugging, and skin atrophy. Lesions are surrounded by an elevated erythematous border. The condition typically involves the face and scalp, but widespread dissemination may occur.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Taylor, AE1
Hindson, C1
Wacks, H1

Other Studies

1 other study available for acebutolol and Lupus Erythematosus, Discoid

ArticleYear
A drug eruption due to acebutolol with combined lichenoid and lupus erythematosus features.
    Clinical and experimental dermatology, 1982, Volume: 7, Issue:2

    Topics: Acebutolol; Humans; Lichen Planus; Lupus Erythematosus, Discoid; Male; Middle Aged

1982